var data={"specialtyName":"Authors and Editors in Psychiatry","contributorTypes":

[{"name":"Editors-in-Chief","contributors":[{"name":"Peter P Roy-Byrne,
MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive
Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of
Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society
(journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock
Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"Murray B
Stein, MD, MPH","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor —
Anxiety Disorders\n","Professor of Psychiatry and Family Medicine & Public
Health\n","University of California San
Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social
anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety
and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic
Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related
Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive
Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity
Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury];
Resilience Therapeutics [PTSD]."}]},{"name":"Deputy Editors","contributors":
[{"name":"Richard Hermann, MD","credentials":["Deputy Editor —
Psychiatry\n","Associate Professor\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"David Solomon, MD","credentials":["Deputy
Editor — Psychiatry\n","Clinical Associate Professor\n","Brown University School of
Medicine"],"disclosure":""}]},{"name":"Section Editors","contributors":
[{"name":"David Brent, MD","credentials":["Section Editor — Childhood Mental
Disorders \n","Professor of Psychiatry, Pediatrics and Epidemiology\n","University
of Pittsburgh School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: NIMH [Child & Adolescent Psychiatry]; AFSP [Suicide prevention].
Consultant/Advisory Boards: Healthwise [Consumer health education (Child
Psychiatry)]; Klingenstein Third Generation Foundation [Postdoctoral fellowships].
Patent Holder: Guilford Press [Psychology (Treating depressed and suicidal
adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]. Other Financial
Interest: Guilford Press [Psychology (Treating depressed and suicidal
adolescents)]; ERT Inc [Cloud platform solution (C-SSRS)]."},{"name":"Joel
Dimsdale, MD","credentials":["Section Editor — Somatic Symptom and Related
Disorders\n","Professor of Psychiatry\n","University of California, San
Diego"],"disclosure":""},{"name":"Paul Keck, MD","credentials":["Section Editor —
Bipolar Disorders\n","Professor of Psychiatry\n","University of Cincinnati College
of Medicine"],"disclosure":"Consultant/Advisory Boards: Otsuka [Bipolar disorder
(Aripiprazole)]; Lyndra. Patent Holder: US Patent [Obsessive-compulsive disorder
(Tramadol)]."},{"name":"Stephen Marder, MD","credentials":["Section Editor —
Psychotic Disorders\n","Professor of Psychiatry\n","Semel Institute of Neuroscience
at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Forum; Neurocrine
[schizophrenia and tardive dyskinesia]. Consultant/Advisory Boards: Takeda, Gideon
Richter, Boeringer-Ingleheim, Otsuka; Allergan; Teva [schizophrenia (brexpiprazole,
cariprazine)]."},{"name":"Susan McElroy, MD","credentials":["Section Editor —
Impulse Control Disorders\n","Professor of Psychiatry\n","University of
Cincinnati"],"disclosure":"Grant/Research/Clinical Support: Allergan [Depression];
Brainsway [Smoking & OCD (Transcranial magnetic stimulation)]; Marriott Foundation
[Bipolar disorder]; Myriad [Bipolar disorder]; Naurex [Depression (GLYX-13)]; Novo
Nordisk [Obesity, Bipolar disorder]; Shire [Binge eating disorder
(Lisdexamfetamine)]; Sunovion[Binge eating disorder]. Consultant/Advisory Boards:
Bracket [Psychiatry]; F Hoffman La Roche, [Psychiatry]; MedAvante [Psychiatry];
Mitsubishi Tanabe Pharma America; Myriad [Bipolar disorder]; Novo Nordisk [Binge
eating disorder]; Shire [Binge eating disorder (Lisdexamfetamine)]; Sunovion [Binge
eating disorder]. Consultant/Advisory Boards (spouse): Shire [Bipolar disorder];
Supernus [Bipolar disorder]; Otsuka [Bipolar disorder]; ProPhase [Bipolar
disorder]; Merck [Bipolar disorder]."},{"name":"Peter P Roy-Byrne,
MD","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Depressive
Disorders\n","Professor of Psychiatry and Behavioral Sciences\n","University of
Washington School of Medicine"],"disclosure":"Employment: Mass Medical Society
(journal Watch); Wiley Lliss (Depression and Anxiety) [Editor in Chief]. Stock
Options: Valant Medical Solutions [behavioral health (EMR)]."},{"name":"Richard
Saitz, MD, MPH, FACP, DFASAM","credentials":["Section Editor — Substance Use
Disorders\n","Professor of Community Health Sciences and Medicine\n","Boston
University Schools of Public Health and Medicine, Boston Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Alkermes
provides study medication for a clinical trial supported by NIH on Alcohol user
disorder (injectable naltrexone)]."},{"name":"Andrew J Saxon, MD","credentials":
["Section Editor — Substance Use Disorders\n","Professor and Director, Addiction
Psychiatry Residency Program, Department of Psychiatry & Behavioral
Sciences\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial
Support: Medicasafe [Medication dispensing]. Consultant/Advisory Boards: Neurocrine
Biosciences [Tardive dyskinesia (Valbenazine)]."},{"name":"Jonathan M Silver,
MD","credentials":["Section Editor — Mental and Medical Disorders\n","Clinical
Professor of Psychiatry\n","New York University School of
Medicine"],"disclosure":""},{"name":"Andrew Skodol, MD","credentials":["Section
Editor — Personality Disorders\n","Research Professor of Psychiatry\n","University
of Arizona College of Medicine"],"disclosure":"Other Financial Interest: American
Psychiatric Publishing (royalties); Merck Manuals (royalties)."},{"name":"David
Spiegel, MD","credentials":["Section Editor — Dissociative Disorders\n","Professor
of Psychiatry and Behavioral Sciences\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Murray B Stein, MD, MPH","credentials":
["Editor-in-Chief — Psychiatry\n","Section Editor — Anxiety Disorders\n","Professor
of Psychiatry and Family Medicine & Public Health\n","University of California San
Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social
anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety
and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic
Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related
Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive
Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity
Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury];
Resilience Therapeutics [PTSD]."},{"name":"Joel Yager, MD","credentials":["Section
Editor — Eating Disorders\n","Professor of Psychiatry\n","University of Colorado
School of Medicine"],"disclosure":""}]},{"name":"Editorial
Assistants","contributors":[{"name":"Jamie Spagnuolo, BA","credentials":["Editorial
Assistant — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":
[{"name":"Jonathan Abramowitz, PhD","credentials":["Professor of
Psychology\n","University of North Carolina at Chapel Hill"],"disclosure":""},
{"name":"Nezam H Afdhal, MD, FRCPI","credentials":["Senior Physician in
Hepatology\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; BMS; Gilead
[HCV Studies]. Consultant/Advisory Boards: AbbVie; Echosens; Gilead Sciences;
GlaxoSmithKline; Jannsen Pharmaceutica; Ligand; Merck & Co; Novartis International
AG; Spring Bank Pharmaceuticals; TRIO HealthCare [Liver Disease]. Equity
Ownership/Stock Options: Spring Bank Pharmaceuticals [HBV, RSV]. Employment: Spring
Bank Pharmaceuticals [HBV, RSV] - No relevant conflict on topic."},{"name":"Marc
Agronin, MD","credentials":["Associate Professor of Psychiatry and
Neurology\n","University of Miami Miller School of Medicine"],"disclosure":""},
{"name":"Ann Marie Albano, PhD, ABPP","credentials":["Professor of Medical
Psychology (in Psychiatry)\n","Columbia
University"],"disclosure":"Consultant/Advisory Boards: University of Maryland for
NIMH [Anxiety]. Other Financial Interest: Oxford Press [Anxiety (Royalties)]."},
{"name":"Pino Alonso, MD, PhD","credentials":["Assistant Professor\n","University
of Barcelona"],"disclosure":""},{"name":"Evan Alvarez, MA","credentials":["Research
Project Coordinator\n","Columbia University, New York State Psychiatric
Institute"],"disclosure":""},{"name":"J Todd Arnedt, PhD","credentials":["Associate
Professor, Departments of Psychiatry and Neurology\n","University of Michigan
Medical School"],"disclosure":""},{"name":"Mark D Aronson, MD","credentials":
["Editor-in-Chief — Primary Care (Adult); Hospital Medicine\n","Section Editor —
General Medicine\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Evelyn Attia, MD","credentials":["Professor of
Psychiatry\n","Columbia University Medical Center"],"disclosure":"Grant/Research
Support: Eli Lilly [Eating disorders (Olanzapine)]."},{"name":"Marilyn Augustyn,
MD","credentials":["Section Editor — Developmental and Behavioral
Pediatrics\n","Associate Professor\n","Boston University School of
Medicine"],"disclosure":""},{"name":"David Avery, MD","credentials":["Professor of
Psychiatry and Behavioral Sciences\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"David Axelson, MD","credentials":["Professor
of Psychiatry\n","The Ohio State University College of
Medicine"],"disclosure":"Consultant/Advisory
Boards: Janssen Research [Bipolar disorder (Risperidone)]."},{"name":"Sudie E
Back, PhD","credentials":["Professor\n","Medical University of South
Carolina"],"disclosure":"Grant/Research/Clinical Trial Support: National Institute
of Health; US Department of Defense; US Department of Veteran Affairs [PTSD and SUD
(COPE treatment therapy manual and patient workbook)]."},{"name":"David Baldwin,
MA, DM FRCPsych","credentials":["Professor of Psychiatry and Head of Mental Health
Group\n","University of Southampton Faculty of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [GAD
(Pregabalin)]. Consultant/Advisory Boards: Lundbeck [Depression (Vortioxetine)];
LivaNova [Depression (VNS)]; Mundipharma [Anxiety (methoxyflurane)]. Other
Financial Interest: AstraZeneca [Depression (Quetiapine)]."},{"name":"David Baron,
MSEd, DO, DFAPA","credentials":["Professor and Vice chair, Department of
Psychiatry\n","Keck School of Medicine at
USC"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [consultant (NFL,
NCAA/PAC-12)]."},{"name":"William C Becker, MD","credentials":["Assistant Professor
of Medicine\n","Yale University School of Medicine"],"disclosure":""},
{"name":"Donna Bender, PhD","credentials":["Clinical Professor of Psychiatry and
Behavioral Sciences\n","Tulane University"],"disclosure":""},{"name":"David
Benedek, MD","credentials":["Professor and Chair\n","Uniformed Services University
School of Medicine"],"disclosure":""},{"name":"Shannon Bennett, PhD","credentials":
["Assistant Professor of Psychology in Psychiatry\n","Weill Cornell Medical
College"],"disclosure":""},{"name":"Boris Birmaher, MD","credentials":["Endowed
Chair in Early Onset Bipolar Disease, Professor of Psychiatry\n","University of
Pittsburgh, School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: National Institutes of Mental Health [Bipolar disorder]. Other Financial
Interests: Royalties for books [Bipolar and major depressive disorders]."},
{"name":"Robert J Birnbaum, MD, PhD","credentials":["Assistant Professor of
Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Donald W Black,
MD","credentials":["Professor of Psychiatry\n","University of Iowa Carver College
of Medicine"],"disclosure":""},{"name":"William V Bobo, MD, MPH","credentials":
["Professor of Psychiatry\n","Mayo College of Medicine"],"disclosure":""},
{"name":"Liza Bonin, PhD","credentials":["Associate Professor of Pediatrics and
Psychiatry\n","Baylor College of Medicine"],"disclosure":""},{"name":"Andrea
Bradford, PhD","credentials":["Baylor College of Medicine\n","Department of
Medicine - Section of Gastroenterology"],"disclosure":""},{"name":"Kathleen Brady,
MD, PhD","credentials":["Professor of Psychiatry\n","Medical University of South
Carolina"],"disclosure":""},{"name":"Raphael J Braga, MD","credentials":["Assistant
Professor of Psychiatry\n","Hofstra University/Northwell Health\n","Center for
Treatment and Research of Bipolar Disorder\n","The Zucker Hillside
Hospital"],"disclosure":""},{"name":"Bethany Brand, PhD","credentials":["Professor
of Psychology \n","Towson University"],"disclosure":""},{"name":"David Brent,
MD","credentials":["Section Editor — Childhood Mental Disorders \n","Professor of
Psychiatry, Pediatrics and Epidemiology\n","University of Pittsburgh School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH [Child &
Adolescent Psychiatry]; AFSP [Suicide prevention]. Consultant/Advisory Boards:
Healthwise [Consumer health education (Child Psychiatry)]; Klingenstein Third
Generation Foundation [Postdoctoral fellowships]. Patent Holder: Guilford Press
[Psychology (Treating depressed and suicidal adolescents)]; ERT Inc [Cloud platform
solution (C-SSRS)]. Other Financial Interest: Guilford Press [Psychology (Treating
depressed and suicidal adolescents)]; ERT Inc [Cloud platform solution (C-
SSRS)]."},{"name":"Richard Bryant, PhD","credentials":["Professor of
Psychology\n","University of New South Wales"],"disclosure":""},{"name":"Robert W
Buchanan, MD","credentials":["Professor of Psychiatry\n","University of Maryland
School of Medicine"],"disclosure":""},{"name":"Oscar Bukstein, MD","credentials":
["Professor of Psychiatry\n","Harvard Medical School"],"disclosure":""},
{"name":"Brenda Bursch, PhD","credentials":["Professor of Clinical Psychiatry &
Biobehavioral Sciences, and Pediatrics\n","David Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Juan Bustillo, MD","credentials":["Professor of
Psychiatry & Neuroscience\n","University of New Mexico"],"disclosure":""},
{"name":"Alexander Bystritsky, MD, PhD","credentials":["Professor of Psychiatry and
Biobehavioral Sciences Director,\n","Anxiety Disorders Program, David Geffen School
of Medicine, University of California, Los Angeles"],"disclosure":""},{"name":"John
S Cacciola, PhD","credentials":["Senior Scientist\n","Treatment Research
Institute\n","Adjunct Professor of Psychology in Psychiatry\n","Perelman School of
Medicine at University of Pennsylvania"],"disclosure":""},{"name":"Eve Caligor,
MD","credentials":["Clinical Professor of Psychiatry\n","Columbia University
College of Physicians and Surgeons"],"disclosure":""},{"name":"Austin R Campbell,
PharmD, BCPP","credentials":["Adjunct Clinical Assistant Professor of Psychiatry
\n","University of Missouri School of Medicine and University of Missouri - Kansas
City School of Pharmacy"],"disclosure":""},{"name":"E Cabrina Campbell,
MD","credentials":["Associate Professor of Psychiatry\n","Perelman School of
Medicine, University of Pennsylvania; Cpl. Michael J. Crescenz VA Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Sunovian
[Schizophrenia/bipolar depression(lurasidone)]."},{"name":"Stanley N Caroff,
MD","credentials":["Professor of Psychiatry\n","Perelman School of Medicine,
University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial
Support:Neurocrine Biosciences, Inc.(Valbenazine). Consultant/Advisory Boards:
Neurocrine Biosciences, Inc. (Valbenazine); Teva Pharmaceuticals, Inc.
(Austedo)."},{"name":"Peijun Chen, MD, MPH, PhD","credentials":["Associate
Professor of Psychiatry\n","Case Western Reserve University School of
Medicine\n","Staff Geriatric Psychiatrist, Louis Stokes Cleveland VA Medical
Center"],"disclosure":""},{"name":"Yujuan Choy, MD","credentials":["Assistant
Clinical Professor of Psychiatry (volunteer faculty)\n","University of California,
Irvine"],"disclosure":""},{"name":"Emil Coccaro, MD","credentials":["Professor of
Psychiatry and Behavioral Neuroscience\n","The University of
Chicago"],"disclosure":"Consultant/Advisory Boards: Azevan Inc [Intermittent
explosive disorder]; Avanir, Inc [Intermittent explosive disorder]. Equity
Ownership/Stock Options: Azevan Inc [Aggression]."},{"name":"M Justin Coffey,
MD","credentials":["Associate Professor of Psychiatry & Behavioral
Sciences\n","Baylor College of Medicine"],"disclosure":""},{"name":"Phillip Coffin,
MD, MIA","credentials":["Director of Substance Use Research\n","Center for Public
Health Research, San Francisco Department of Public Health"],"disclosure":""},
{"name":"Judith A Cohen, MD","credentials":["Professor of Psychiatry\n","Drexel
University College of Medicine"],"disclosure":"Grant/ Research Support: NIMH;
NICHD; SAMHSA [TF-CBT research]. Other Financial Interest: Guilford Press [TF-CBT
(TF-CBT treatment books)]."},{"name":"Francesc Colom, PhD, PsyD,
MSc","credentials":["Senior Researcher\n","Mental Health Program\n","Hospital del
Mar Medical Research Institute\n","CIBERSAM"],"disclosure":""},{"name":"K Ryan
Connolly, MD, MS","credentials":["Clinical Assistant Professor of
Psychiatry\n","University of Pennsylvania School of Medicine"],"disclosure":""},
{"name":"Christoph U Correll, MD","credentials":["Professor of Psychiatry and
Molecular Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
[Schizophrenia, Depression (lurasidone, Vortioxetine)]. Consultant/Advisory Boards:
Alkermes [Schizophrenia, Depression(Aripiprazole Lauroxil, ALKS-3831,ALKS-5461)];
Bristol-Meyers Squibb[Schizophrenia( Aripiprazole )];
Forum[Schizophrenia( Encenicline)]; IntraCellular Therapies[Schizophrenia( ITI-
007)]; Janssen/J&J[Schizophrenia( Risperdal Consta, Paliperidone Palmitate)]; LB
Pharma [Schizophrenia( Amisulpride)]; Lundbeck [Schizophrenia,(Abilify Maintena)],
[Depression (Brexpiprazole, Vortioxetine, Lu AF35700)];
Neurocrine[Schizophrenia( Valbenazine)]; Otsuka[Schizophrenia,( Abilify Maintena,
Brexpiprazole)],[Depression(Brexpiprazole, Vortioxetine)];
Pfizer[Schizophrenia( Ziprasidone)]; Sunovion[Schizophrenia( Lurasidone)];
Supernus[Schizophrenia( Molindone-ER)]; Takeda[Schizophrenia,( Lurasidone)];
[Depression(Vortioxetine)]; Teva [Schizophrenia( Subcutaneous injectable
antipsychotic formulations)]."},{"name":"William Coryell, MD","credentials":
["Professor of Psychiatry\n","University of Iowa, Carver College of
Medicine"],"disclosure":""},{"name":"Michelle Craske, PhD","credentials":
["Director, Anxiety Research Center\n","University of California, Los Angeles
Department of Psychology"],"disclosure":"Grant/Research/Clinical Trial Support:
National Institute of Mental Health [Anxiety and depression (Cognitive and
behavioral treatment)]. Other Financial Interest: Oxford University Press
[Cognitive and behavioral therapy for anxiety disorders (Book royalties)]."},
{"name":"Scott J Crow, MD","credentials":["Professor of Psychiatry\n","University
of Minnesota"],"disclosure":""},{"name":"Larry Culpepper, MD, MPH","credentials":
["Professor of Family Medicine\n","Boston University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Jazz [Behavioral health-sleep
(solriamfetol)]; Lundbeck A/S [Behavioral health (vortioxetine)]; Merck [Behavioral
health (suvorexant)]; Sunovion Pharmaceuticals Inc [Behavioral health
(lurasidone)].
Equity Ownership/Stock Options: M-3 Information, LLC [Behavioral health (My Mood
Monitor)]. Other Financial Interest: Physicians Postgraduate Press [Behavioral
health (Editor in Chief of the \"Primary Care Companion for CNS Diseases\")]."},
{"name":"Colin S Cunningham, PhD","credentials":["Baltimore, MD"],"disclosure":""},
{"name":"Michael Davis, MD, PhD","credentials":["Assistant Professor of Psychiatry
& Behavioral Sciences\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Pelle P de Koning, MD","credentials":["Department of Psychiatry, Academic
Medical Center (AMC), \n","University of Amsterdam, Amsterdam, The
Netherlands"],"disclosure":""},{"name":"Valdesha DeJean, MD","credentials":
["Pacific Medical Centers - Canyon Park Clinic"],"disclosure":""},{"name":"Damiaan
Denys, MD, PhD","credentials":["Professor of Psychiatry\n","Academic Medical
Center, University of Amsterdam\n","Netherlands Institute for Neuroscience, an
institute of the KNAW, Amsterdam"],"disclosure":"Other Financial Interest:
Medtronic [DBS (DBS research)]."},{"name":"Michael Devlin, MD","credentials":
["Professor of Clinical Psychiatry\n","Columbia University College of Physicians
and Surgeons"],"disclosure":""},{"name":"Alice D Domar, PhD","credentials":
["Associate Professor of Obstetrics, Gynecology and Reproductive Biology (part-
time)\n","Harvard Medical School"],"disclosure":"Speaker's Bureau: Merck [Stress
and stress reduction]; Ferring [Stress and stress reduction]. Equity
Ownership/Stock Options: TriaDea [Impact of supplements on fertility
(Vitamins/supplements)]; FertiCalm (App to teach mind/body skills to infertility
patients); FertiStrong (App to teach mind/bpdy skills to men experiencing
infertility)."},{"name":"Frank J Domino, MD","credentials":["Professor of Family
Medicine\n","University of Massachusetts Medical School"],"disclosure":""},
{"name":"Karen L Dugosh, PhD","credentials":["Senior Scientist\n","Treatment
Research Institute"],"disclosure":""},{"name":"Yael Dvir, MD","credentials":
["Assistant Professor of Psychiatry\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Scott Engel, PhD","credentials":["Research
Scientist\n","Neuropsychiatric Research Institute"],"disclosure":""},
{"name":"Randall T Espinoza, MD, MPH","credentials":["Clinical Professor of
Psychiatry\n","University of California, Los Angeles"],"disclosure":""},
{"name":"Lorena Fernández de la Cruz, PhD","credentials":["Assistant
Professor\n","Karolinska Institutet"],"disclosure":""},{"name":"Bernard A Fischer,
MD","credentials":["Assistant Professor of Psychiatry\n","University of Maryland
School of Medicine"],"disclosure":""},{"name":"Brad Foote, MD","credentials":
["Associate Clinical Professor\n","Albert Einstein College of Medicine, Yeshiva
University"],"disclosure":""},{"name":"Sara F Forman, MD","credentials":["Assistant
Professor in Pediatrics\n","Harvard Medical School"],"disclosure":"Other Financial
Interest: Pediatric endocrine meeting [Eating disorders (Honorarium)]."},
{"name":"Jean Frazier, MD","credentials":["Professor of Psychiatry and
Pediatrics\n","University of Massachusetts Medical
School"],"disclosure":"Grant/Research Support: NIMH; NICHD; Alcobra [Fragile X
Syndrome (Metadoxine M601C1)]; Neuren [Fragile X Syndrome (Glycyl-L-2-Methylpropyl-
L-Glutamic Acid)]; Roche [Fragile X Syndrome (Metabotropic Glutamate 5 Negative
Allosteric Modulator)]; SyneuRx [Schizophrenia (Sodium Benzoate)]. Other Financial
Interest: Forest [Depression (Vilazodone)]; Data Safety Monitoring Board."},
{"name":"Oliver Freudenreich, MD","credentials":["Associate Professor of
Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Avanir [Schizophrenia (AVP-786)]; Janssen [Schizophrenia (long-acting
injectable)]; Otsuka [Schizophrenia (brexpiprazole)]. Consultant/Advisory Boards:
Janssen [Schizophrenia drug development]. Other Financial Interest: Global Medical
Education [CME talk on schizophrenia]."},{"name":"Paul A Frewen,
PhD","credentials":["Assistant Professor of Psychiatry\n","University of Western
Ontario"],"disclosure":""},{"name":"Glen Gabbard, MD","credentials":["Professor of
Psychiatry\n","SUNY Upstate Medical University\n","Clinical Professor of
Psychiatry\n","Baylor College of Medicine"],"disclosure":""},{"name":"Bradley N
Gaynes, MD, MPH","credentials":["Professor of Psychiatry, Associate Chair for
Psychiatry Research Training and Education \n","University of North Carolina School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: M-3 [Research to
assess feasibility of administering a general psychiatric screening and monitoring
tool in psychiatric clinics]."},{"name":"Michael Gitlin, MD","credentials":
["Professor of Clinical Psychiatry\n","Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Andrew Goddard, MD","credentials":["Professor of
Psychiatry, UCSF\n","UCSF Fresno Medical Education & Research
Program"],"disclosure":"Grant/Research/Clinical Trial Support: Central California
Faculty Medical Group [Anxiety disorder (Suvorexant)]; National Network of
Depression Centers [Multisite trial of biomarkers of ketamine response in TRD]."},
{"name":"Adam J Gordon, MD, MPH, FACP, FASAM","credentials":["Professor of Medicine
and Psychiatry\n","University of Utah School of Medicine"],"disclosure":""},
{"name":"David A Gorelick, MD, PhD","credentials":["Professor of
Psychiatry\n","University of Maryland School of Medicine"],"disclosure":""},
{"name":"Leah Gramlich, MD, FRCPC","credentials":["Professor of
Medicine\n","University of Alberta"],"disclosure":"Speaker's Bureau: Abbott
[malnutrition (Ensure)]."},{"name":"Sophie Grigoriadis, MD, MA, PhD,
FRCPC","credentials":["Associate Professor of Psychiatry\n","University of
Toronto\n","Sunnybrook Health Sciences Centre"],"disclosure":"Speaker's Bureau:
Pfizer [Depression]. Consultant/Advisory Boards: Allergan [Depression
(Levomilnacipran)]; Actavis [Depression (Vilazodone)]; Sage [Postpartum
depression]."},{"name":"Derrick Hamaoka, LtCol, USAF, MC, FS","credentials":
["Associate Professor\n","Uniformed Services University of the Health
Sciences"],"disclosure":""},{"name":"Karen Hartwell, MD","credentials":["Associate
Professor\n","Medical University of South Carolina"],"disclosure":""},
{"name":"Victoria Hendrick, MD","credentials":["Clinical Professor\n","Department
of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine,
UCLA"],"disclosure":""},{"name":"Richard Hermann, MD","credentials":["Deputy Editor
— Psychiatry\n","Associate Professor\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"Michael Hirsch, MD","credentials":["Instructor
in Psychiatry\n","Harvard Medical School"],"disclosure":""},{"name":"Stefan G
Hofmann, PhD","credentials":["Professor of Psychology\n","Boston
University"],"disclosure":""},{"name":"Jean L Holley, MD, FACP","credentials":
["Clinical Professor of Medicine\n","University of Illinois, Urbana-
Champaign"],"disclosure":""},{"name":"Stephen R Holt, MD, MS, FACP","credentials":
["Assistant Professor of Medicine\n","Yale School of Medicine"],"disclosure":""},
{"name":"Paul E Holtzheimer, MD","credentials":["Associate Professor of Psychiatry
and Surgery\n","The Geisel School of Medicine at
Dartmouth"],"disclosure":"Grant/Research/Clinical Trial Support: NeoSync
[Depression (TMS device)]."},{"name":"Karen Ingersoll, PhD","credentials":
["Associate Professor of Psychiatry and Neurobehavioral Sciences\n","University of
Virginia School of Medicine"],"disclosure":""},{"name":"Michael R Irwin,
MD","credentials":["Cousins Professor of Psychiatry and Biobehavioral Sciences,
David Geffen School of Medicine at UCLA\n","Professor of Psychology, UCLA College
of Letters and Sciences"],"disclosure":""},{"name":"Philip G Janicak,
MD","credentials":["Adjunct Professor, Department of Psychiatry and Behavioral
Sciences\n","Northwestern University, Feinberg School of
Medicine"],"disclosure":"Speaker's Bureau: Neuronetics [Depression (transcranial
magnetic stimulation)]; TMS Solutions [Depression (transcranial magnetic
stimulation)]. Consultant/ Advisory Boards: Neuronetics [Depression (transcranial
magnetic stimulation)]; Otsuka [Psychosis (participate in their nonpromotional
PsyhU program on various topics, including mood and psychotic disorders)]."},
{"name":"Robin B Jarrett, PhD","credentials":["Elizabeth H. Penn Professor in
Clinical Psychology\n","The University of Texas Southwestern Medical
Center"],"disclosure":""},{"name":"Michael D Jibson, MD, PhD","credentials":
["Professor of Psychiatry\n","University of Michigan"],"disclosure":""},
{"name":"Bankole A Johnson, DSc, MD, MBChB, MPhil, FRCPsych, DFAPA","credentials":
["The Dr. Irving J. Taylor Professor and Chair in the Department of
Psychiatry\n","Professor of Pharmacology and Professor of Anatomy &
Neurobiology\n","Director of the Brain Science Research Consortium \n","University
of Maryland School of Medicine"],"disclosure":"Consultant/Advisory Boards: ADial
Pharmaceuticals [Addiction (Ondansetron)]; D&A Pharma [Addiction]. Equity
Ownership/Stock Options: ADial Pharmaceuticals [Addiction (Ondansetron)]; Kole Life
Foods [Food and wellness products]; Pepco [Psychological services (Brief behavioral
compliance enhancement treatment)]."},{"name":"Kyle Kampman, MD","credentials":
["Associate Professor of Psychiatry\n","Perelman School of Medicine, University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Braeburn
[Opioid use disorder]."},{"name":"John Kane, MD","credentials":["Professor of
Psychiatry and Molecular Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Schizophrenia
(Aripiprazole)]; Lundbeck [Schizophrenia (Long-acting aripiprazole)]; Intracellular
Therapeutics [Drug development]; Janssen Pharmaceutica [Schizophrenia (Risperidone,
paliperidone)]; Johnson and Johnson
[Schizophrenia (Risperidone, paliperidone)]; Otsuka [Schizophrenia
(Aripiprazole)]; Reviva [Drug development]; Roche [Drug development]; Sunovion
[Schizophrenia (Lurasidone)]; Teva [Drug development]. Equity Ownership/Stock
Options: MedAvante, Inc [Assessment in clinical trials]; Vanguard Research Group
[Conduct of clinical trials]; LB Pharmaceuticals, Inc [Drug development]. Other
Financial Interest: Janssen; Genentech; Otsuka (honoraria)."},{"name":"Jason
Karlawish, MD","credentials":["Professor of Medicine\n","Medical Ethics and Health
Policy\n","University of Pennsylvania"],"disclosure":""},{"name":"Brooks Keeshin,
MD","credentials":["Assistant Professor of Pediatrics\n","University of
Utah"],"disclosure":""},{"name":"Gabor Keitner, MD","credentials":["Professor of
Psychiatry\n","Brown University"],"disclosure":""},{"name":"Charles Kellner,
MD","credentials":["Professor of Psychiatry\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Other Financial Interest: Cambridge University Press
(honoraria); Psychiatric Times (paid contributor); Northwell Health (honoraria for
teaching ECT course)."},{"name":"Stephanie Kennebeck, MD","credentials":["Associate
Professor of Clinical Pediatrics\n","Cincinnati Children’s Hospital Medical
Center\n","University of Cincinnati School of Medicine"],"disclosure":""},
{"name":"Jay S Keystone, MD, MSc (CTM), FRCPC","credentials":["Professor of
Medicine\n","University of Toronto, Canada"],"disclosure":""},{"name":"Mary C
Kimmel, MD","credentials":["Clinical Assistant Professor of Psychiatry\n","UNC
Chapel Hill"],"disclosure":"Equity Ownership/Stock Options (Spouse): Abbvie and
Abbott Laboratories."},{"name":"Taishiro Kishimoto, MD","credentials":["Assistant
Professor of Neuropsychiatry \n","Keio University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka
[Schizophrenia (Aripiprazole)]. Speaker’s Bureau: Otsuka [Schizophrenia
(Aripiprazole)]; Lilly [Schizophrenia (Olanzapine)]; Janssen [Schizophrenia
(Risperidone, Paliperidone)]."},{"name":"Diane Klein, MD","credentials":["Associate
Professor of Clinical Psychiatry\n","New York University School of
Medicine"],"disclosure":""},{"name":"Ranga Krishnan, MD","credentials":["Professor
of Psychiatry\n","Duke University School of Medicine"],"disclosure":""},
{"name":"Ralph Kupka, MD, PhD","credentials":["Professor of Psychiatry \n","VU
University Medical Center, Amsterdam, the Netherlands"],"disclosure":"Speaker's
Bureau: AstraZeneca; Lundbeck [Bipolar disorder (aripiprazole)]."},{"name":"Ruth
Lanius, MD, PhD","credentials":["Professor of Psychiatry\n","The University of
Western Ontario"],"disclosure":""},{"name":"John Lauriello, MD","credentials":
["Professor of Psychiatry\n","University of
Missouri"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka; Alkermes
[Schizophrenia (Lurasidone, Aripiprazole LAI, Paliperidone LAI)].
Consultant/Advisory Boards: Sunovion; Janssen; Otsuka; Reckitt; Benckiser
[Schizophrenia (Lurasidone, Paliperidone LAI, Aripiprazole LAI)]; Teva [Tardive
dyskinesia (Medication not yet approved)]."},{"name":"Kimberly Glazier Leonte,
PhD","credentials":["Clearview Horizons"],"disclosure":""},{"name":"James L
Levenson, MD","credentials":["Professor of Psychiatry, Medicine, and
Surgery\n","Virginia Commonwealth University School of Medicine"],"disclosure":""},
{"name":"Stephen B Levine, MD","credentials":["Clinical Professor of
Psychiatry\n","Case Western Reserve University School of
Medicine"],"disclosure":""},{"name":"Mitchell Levy, MD","credentials":["Assistant
Professor of Health Services and Psychiatric Epidemiology\n","University of
Washington School of Medicine"],"disclosure":""},{"name":"Richard J Loewenstein,
MD","credentials":["Medical Director, The Trauma Disorders Program\n","Sheppard
Pratt Health System"],"disclosure":""},{"name":"Julie Lord, MD","credentials":
["Assistant Residency Training Director,\n","University of Washington Outpatient
Psychiatry Clinic"],"disclosure":""},{"name":"Jeffrey M Lyness, MD","credentials":
["Senior Associate Dean for Academic Affairs\n","Professor of Psychiatry and
Neurology\n","University of Rochester Medical Center"],"disclosure":""},
{"name":"Stephan C Mann, MD, DLFAPA","credentials":["Lenape Valley
Foundation"],"disclosure":""},{"name":"Theo Manschreck, MD","credentials":
["Professor of Psychiatry\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [early
psychosis (aripiprazole)]. Consultant/Advisory Boards: Otsuka-Lundbeck [new
antidepressant]."},{"name":"Stephen Marder, MD","credentials":["Section Editor —
Psychotic Disorders\n","Professor of Psychiatry\n","Semel Institute of Neuroscience
at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Forum; Neurocrine
[schizophrenia and tardive dyskinesia]. Consultant/Advisory Boards: Takeda, Gideon
Richter, Boeringer-Ingleheim, Otsuka; Allergan; Teva [schizophrenia (brexpiprazole,
cariprazine)]."},{"name":"Scott F Martin, MD","credentials":["Clinical
Instructor\n","Case Western Reserve University School of
Medicine"],"disclosure":""},{"name":"David Mataix-Cols, PhD","credentials":
["Professor of Child and Adolescent Psychiatric Science\n","Karolinska
Institutet"],"disclosure":""},{"name":"Randi E McCabe, PhD","credentials":
["Professor of Psychiatry & Behavioural Neurosciences\n","McMaster
University"],"disclosure":""},{"name":"Joseph McEvoy, MD","credentials":["Professor
of Psychiatry and Health Behavior \n","Medical College of
Georgia"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes, Avanir,
BoehringerIngleheim, Otsuka, Teva[SCHIZOPHRENIA (TARDIVE DYSKINESIA)].
Consultant/Advisory Boards: Jazz, Neurocrine, Teva [Schizophrenia (Olanzapine,
clozapine)]."},{"name":"James R McKay, PhD","credentials":["Professor of Psychology
in Psychiatry\n","University of Pennsylvania"],"disclosure":""},{"name":"Kimberly D
McLaren, MD","credentials":["Assistant Professor of Health Services and Psychiatric
Epidemiology\n","University of Washington Medical School"],"disclosure":""},
{"name":"Katie McLaughlin, PhD","credentials":["Associate Professor, Department of
Psychology\n","University of Washington"],"disclosure":""},{"name":"Philip Mehler,
MD","credentials":["Chief Medical Officer, Eating Recovery Center\n","Executive
Medical Director, ACUTE, Denver Health\n","Professor of Medicine, University of
Colorado"],"disclosure":""},{"name":"Samantha Meltzer-Brody, MD,
MPH","credentials":["Associate Professor and Associate Chair for Faculty
Development\n","Director, UNC Perinatal Psychiatry Program\n","UNC Center for
Women’s Mood Disorders"],"disclosure":"Grant/Research/Clinical Trial Support: Sage
Pharmaceuticals [Postpartum depression (Investigational medication)]; Janssen
[Postpartum depression (research)]."},{"name":"Lisa J Merlo, PhD,
MPE","credentials":["Assoicate Professor of Psychiatry\n","University of
Florida"],"disclosure":""},{"name":"James E Mitchell, MD","credentials":["Professor
- Department of Psychiatry and Behavioral Science\n","University of North Dakota
School of Medicine and Health Sciences\n","\n","Research
Scientist\n","Neuropsychiatric Research Institute"],"disclosure":""},{"name":"Ramin
Mojtabai, MD, PhD, MPH","credentials":["Professor of Mental Health\n","Johns
Hopkins Bloomberg School of Public Health"],"disclosure":""},{"name":"C Scott
Moreland, DO","credentials":["Clinical Assistant Professor\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Peter Na, MD","credentials":["New York
University Department of Psychiatry"],"disclosure":""},{"name":"Craig Nelson,
MD","credentials":["Professor of Psychiatry\n","University of California San
Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Avid [PET imaging
(Florbetapir)]. Consultant/Advisory Boards: Lundbeck [Depression (Brexpiprazole)];
Otsuka [Depression (Brexpiprazole)]; Janssen [Depression (esketamine)]; Assurex
[Bipolar disorder (Genetic assay)]; Eisai [Insomnia (Lemborexant)]. Equity
Ownership/Stock: Atossa [Breast cancer (Device)]. Other Honoraria: Otsuka Asia
[Depression (Aripiprazole)]; Lundbeck [Depression (Brexpiprazole)]."},
{"name":"Andrew Nierenberg, MD","credentials":["Professor of Psychiatry\n","Harvard
Medical School, Massachusetts General
Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda/Lundbeck
[MDD (Vortioxetine)]; PamLabs [MDD (L-methylfolate)]; GlaxoSmithKlein [MDD
(Lamotrigine, Bupropion)]; Alkermes [MDD (Naltrexone)]; NeuroRx Pharma [MDD (D-
cycloserine, Lurasidone)]; PAREXEL [MDD (Pharmaceutical company, clinical research
organization)]; Janssen Pharmaceuticals [Bipolar Disorder (longitudinal study in
offspring of parents with BD)]. Consultant/Advisory Boards: Takeda/Lundbeck [MDD
(Vortioxetine)]; Sunovian [MDD (Lurasidone)]; PamLabs [MDD (L-methylfolate)];
Naurex [MDD (GLX-13, NRX-1074)]; Hoffman La Roche/Genentech [MDD (R04917838)]; Eli
Lilly and Company [MDD (Dulexetine)]; Pfizer [Desvenlafaxine]; NeuroRx Pharma
[MDD/Bipolar Disorder]; Jazz Pharmaceuticals. Honoraria: SLACK Publishing
[Publisher]; Physician’s Postgraduate Press, Inc. [Publisher]."},{"name":"Patrick G
O'Connor, MD, MPH","credentials":["Professor of Medicine\n","Yale School of
Medicine"],"disclosure":""},{"name":"Christine Pace, MD, MSc","credentials":
["Assistant Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Tae Woo Park, MD, MSc","credentials":
["Assistant Professor of Psychiatry\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Martin Paulus, MD","credentials":["Adjunct
Professor of Psychiatry\n","University of California San Diego"],"disclosure":""},
{"name":"Jennifer Payne, MD","credentials":["Associate Professor of
Psychiatry\n","Johns Hopkins School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Sage Therapeutics
[Postpartum depression (Allopregnanolone)].
Consultant/Advisory Boards: Sage Therapeutics [Postpartum depression
(Allopregnanolone)]\r\nJanssen [Relapse Adjudication Committee (Esketamine,
haloperidol, paliperidone, risperdone)]. Other Financial Interest: Eli Lily [Legal
consulting (Duloxetine, fluoxetine, olanzapine)]; Abbott Pharmaceuticals [Legal
consulting (fluvoxamine, valproic acid)]"},{"name":"Michelle Peavy","credentials":
["Research and Training Manager\n","Evergreen Treatment
Services"],"disclosure":""},{"name":"Mark J Petrini, MD","credentials":["Assistant
Clinical Professor of Medicine and Psychiatry\n","Columbia University Medical
Center"],"disclosure":""},{"name":"Katharine A Phillips, MD","credentials":
["Professor of Psychiatry and Human Behavior\n","Warren Alpert Medical School of
Brown University\n","Assistant Professor of Psychiatry \n","Weill Cornell Medical
College (appointment to Professor in progress)"],"disclosure":"Other Financial
Interest: Oxford University Press [Body dysmorphic disorder (royalties)]; Merck
Manual [Obsessive compulsive and related disorders (honoraria)]; International
Creative Management [Body dysmorphic disorder (agent for books)]; Guilford
Publications [Body dysmorphic disorder (royalties)]; American Psychiatric
Publishing [Obsessive-compulsive and related disorders (potential future
royalties)], Royal Pharma [body dysmorphic disorder and olfactory reference
syndrome (honorarium)], The Free Press [Body image in men (potential future
royalties)]."},{"name":"Andrew A Pieper, MD, PhD","credentials":["Investigator, The
Harrington Discovery Institute \n","\n","Professor of Psychiatry \n","Case Western
Reserve University"],"disclosure":""},{"name":"Kathleen Pike, PhD","credentials":
["Professor of Psychology and Psychiatry\n","Columbia
University"],"disclosure":""},{"name":"Robert M Post, MD","credentials":["Clinical
Professor of Psychiatry\n","George Washington University"],"disclosure":"Speaker's
Bureau: AstraZeneca [Bipolar (Quetiapine)]; Sunovion [Bipolar (Lurasidone)];
Validus [Bipolar (Carbamazepine)]; Takeda [Unipolar (Vortioxetine)];
NestleHealthSci [Unipolar (L-methylfolate)]."},{"name":"Anthony Puliafico,
PhD","credentials":["Assistant Professor of Medical Psychology (in
Psychiatry)\n","Columbia University"],"disclosure":""},{"name":"Adam Rahman, MD,
DABIM, FRCPC","credentials":["Assistant Professor of Medicine\n","University of
Western Ontario"],"disclosure":""},{"name":"Charles L Raison, MD","credentials":
["Professor, Department of Psychiatry\n","School of Medicine and Public
Health\n","University of Wisconsin-Madison"],"disclosure":"Consultant/Advisory
Boards: Usona Institute [Depression and anxiety (Psilocybin)]; Emory
Healthcare,\r\n[wellbeing]; Lundback/Otsuka [bipolar disorder]; North American
Center for Continuing Medical Education."},{"name":"Charles F Reynolds III,
MD","credentials":["UPMC Endowed Professor in Geriatric Psychiatry\n","Director,
Advanced Center for Interventions and Services Research in Late-Life Depression
Prevention and Treatment, and the Hartford Center of Excellence in Geriatric
Psychiatry\n","Director, Aging Institute of UPMC Senior Services and the University
of P"],"disclosure":""},{"name":"Diana Robinson, MBBS FACSEP","credentials":["Chair
and Chief Project Manager\n","Specialist Training Program Education
Projects\n","Australasian College of Sport and Exercise
Physicians"],"disclosure":""},{"name":"Daniel R Rosell, MD, PhD","credentials":
["Assistant Professor of Psychiatry\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"David Rosenberg, MD","credentials":["Professor
and Chair of Psychiatry and Behavioral Neurosciences\n","Wayne State
University"],"disclosure":""},{"name":"Barbara O Rothbaum, PhD","credentials":
["Professor of Psychiatry\n","Emory University School of
Medicine"],"disclosure":"Equity Ownership/Stock Options: Virtually Better [Virtual
reality]."},{"name":"Anthony J Rothschild, MD","credentials":["Irving S. and Betty
Brudnick Endowed Chair and Professor of Psychiatry \n","University of Massachusetts
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: NIMH
[Psychotic depression (Sertraline, Olanzapine)]; Alkermes [Depression (ALKS-5461)];
Janssen [Depression (Esketamine)]; Takeda [Depression (Vortioxetine)]; Allergan
[Depression (Rapastinel)]. Consultant/Advisory Boards: Eli Lilly [Depression,
Suicide (Olanzapine)]; GlaxoSmithKline [Depression, Suicide (Paroxetine)]; Alkermes
[Depression (ALK-5461); Sanofi [Insomnia (zolpidem)]; Sage Therapeutics [Depression
(Sage-217)]."},{"name":"Peter P Roy-Byrne, MD","credentials":["Editor-in-Chief —
Psychiatry\n","Section Editor — Depressive Disorders\n","Professor of Psychiatry
and Behavioral Sciences\n","University of Washington School of
Medicine"],"disclosure":"Employment: Mass Medical Society (journal Watch); Wiley
Lliss (Depression and Anxiety) [Editor in Chief]. Stock Options: Valant Medical
Solutions [behavioral health (EMR)]."},{"name":"John A Rush, MD","credentials":
["Professor Emeritus\n","National University of Singapore, Duke-
NUS"],"disclosure":"Speaker’s Bureau: Stanford University [Depression]; Global
Medical Education Inc [Depression]; Sing-Health [Depression]; University of Montana
[Depression]; John Peter Smith Health [Depression]. Consultant/Advisory Boards:
Sunovion [Depression (Lurasidone)]; Brain Resource, Inc [Depression]; Curbstone
Consultant LLC; Eli Lilly [Depression]; Emmes Corp [Substance use disorder]; Mind
Linc [Depression]; Montana State University [Depression]; UT Southwestern Medical
Center at Dallas [Mentoring]; Texas Tech [Mentoring]; Other Financial Support:
Guilford Press (royalties); UT Southwestern (royalties)."},{"name":"Moira A Rynn,
MD","credentials":["Professor of Psychiatry\n","Columbia
University"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Anxiety
(Guanfacine)]; NIMH [Anxiety (Minocycline)]."},{"name":"Richard Saitz, MD, MPH,
FACP, DFASAM","credentials":["Section Editor — Substance Use
Disorders\n","Professor of Community Health Sciences and Medicine\n","Boston
University Schools of Public Health and Medicine, Boston Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Alkermes
provides study medication for a clinical trial supported by NIH on Alcohol user
disorder (injectable naltrexone)]."},{"name":"Martha Sajatovic, MD","credentials":
["Director of Geriatric Psychiatry\n","Professor of Psychiatry\n","Case Western
Reserve University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Alkermes (Long-acting injectable aripiprazole); Janssen [Schizophrenia
(Paliperidone palmitate)]; Reuter Foundation [Schizophrenia (Haloperidol,
paliperidone palmitate)]; Woodruff Foundation [Schizophrenia (Haloperidol,
paliperidone palmitate)]; Reinberger Foundation [Schizophrenia (Haloperidol,
paliperidone palmitate)]; National Institute of Health [Schizophrenia].
Consultant/Advisory Boards: Bracket [Rater training]; Otsuka [Schizophrenia and
bipolar disorder]; Pfizer [Schizophrenia and bipolar disorder]; Sunovion
[Schizophrenia and bipolar disorder (Lurasidone)]; Neurocrine [Parkinson's
(Valbenazine)], Supernus [Bipolar Disorder (Carbamazepine)]. Other Financial
Interest: Springer Press; Johns Hopkins University Press; Oxford Press
(royalties)."},{"name":"Jitender Sareen, MD, FRCPC","credentials":["Professor and
Department of Psychiatry, Max Rady College of Medicine, University of
Manitoba"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson."},
{"name":"Rebecca J Schmidt, DO, FACP","credentials":["Professor of
Medicine\n","West Virginia University School of Medicine"],"disclosure":""},
{"name":"Franklin R Schneier, MD","credentials":["Special Lecturer in
Psychiatry\n","Columbia University"],"disclosure":"Grant/Research/Clinical Trial
Support: Allergan [Social anxiety disorder (Vilazodone)]."},{"name":"Jennifer
Schreiber, MD","credentials":["Georgetown University Hospital"],"disclosure":""},
{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief —
Rheumatology\n","Section Editor — Basic Science\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Zindel Segal, PhD,
C.Psych","credentials":["Professor of Psychiatry \n","University of
Toronto"],"disclosure":""},{"name":"Kevin Sevarino, MD","credentials":["Assistant
Clinical Professor of Psychiatry\n","Yale University School of
Medicine"],"disclosure":""},{"name":"Michael Sharpe, MD","credentials":["Professor
of Psychological Medicine \n","University of Oxford"],"disclosure":""},{"name":"M
Katherine Shear, MD","credentials":["Professor of Psychiatry\n","Columbia
University"],"disclosure":"Grant/Research/Trial Support: Department of Defense,
Congressionally Directed Research Programs [Interpersonal psychiatry (grant W81XWH-
15-2-0043)]; New York Life Foundation [Interpersonal psychiatry]."},
{"name":"Richard C Shelton, MD","credentials":["Charles Byron Ireland
Chair\n","Professor and Vice Chair for Research\n","UAB Department of Psychiatry
and Behavioral Neurobiology"],"disclosure":"Grant/Research/Clinical Trial Support:
Acadia [Depression (Pimivanserin)] Alkermes [Depression (ALKS-5461)]; Allergan
[Bipolar disorder (cariprazine, levomilnacipran, rapastinel)]; Assurex [Depression
(Genetic test)]; Avanir [Depression (AVP-786)]; Cerecor [Depression (CERC-301)];
Janssen Pharmaceuticals [Depression (Eskatamine intranasal)]; Otsuka [Bipolar
(Aripiprazole)]; Genomind (Genetic test). Consultant/Advisory Boards: Allergan
[Depression (rapastinel, NRX1074)]; Cerecor [Depression (CERC-301; CERC-501)];
Janssen Pharmaceuticals [Depression (Eskatamine intranasal)]; MSI Methylation
Sciences [Depression (S-adenosylmethione)]; Pfizer [Smoking cessation
(Varenicline)]."},{"name":"Jonathan M Silver, MD","credentials":["Section Editor —
Mental and Medical Disorders\n","Clinical Professor of Psychiatry\n","New York
University
School of Medicine"],"disclosure":""},{"name":"Daphne Simeon, MD","credentials":
["Associate Clinical Professor\n","Mount Sinai School of
Medicine"],"disclosure":""},{"name":"Gregory Simon, MD, MPH","credentials":["Kaiser
Permanente Washington Health Research Institute \n","University of Washington
Department of Psychiatry and Behavioral
Sciences"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
Pharmaceuticals [Depression in psoriasis]."},{"name":"Naomi M Simon, MD,
MSc","credentials":["Director, Anxiety and Complicated Grief Program\n","NYU
Langone Health, NYU Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: American Foundation for Suicide Prevention; Department of Defense;
Highland Street Foundation; NIH, Janssen. Speaker's Bureau: MGH Academy. Equity
(spouse): G1Therapeutics, Gatekeeper."},{"name":"Helen Blair Simpson, MD,
PhD","credentials":["Professor of Psychiatry\n","Columbia University Medical
Center, College of Physicians and Surgeons, Columbia
University"],"disclosure":"Grant/Research/Clinical Trial Support: Biohaven
(investigational drug). Other Financial Interest: Cambridge University Press
(royalties)."},{"name":"Samuel G Siris, MD","credentials":["Professor Emeritus of
Psychiatry\n","Hofstra University/Northwell Health"],"disclosure":""},
{"name":"Brian Skehan, MD, PhD","credentials":["Assistant Professor of Psychiatry
and Pediatrics\n","University of Massachusetts Medical School"],"disclosure":""},
{"name":"Andrew Skodol, MD","credentials":["Section Editor — Personality
Disorders\n","Research Professor of Psychiatry\n","University of Arizona College of
Medicine"],"disclosure":"Other Financial Interest: American Psychiatric Publishing
(royalties); Merck Manuals (royalties)."},{"name":"Mary V Solanto,
PhD","credentials":["Associate Professor of Psychiatry\n","NYU School of
Medicine"],"disclosure":""},{"name":"David Solomon, MD","credentials":["Deputy
Editor — Psychiatry\n","Clinical Associate Professor\n","Brown University School of
Medicine"],"disclosure":""},{"name":"Joanna L Starrels, MD, MS","credentials":
["Associate Professor of Medicine\n","Albert Einstein College of Medicine &
Montefiore Medical Center"],"disclosure":"Grant/Research/Clinical Trial
Support:\tOpioid Postmarketing Requirement Consortium [co-investigator on an FDA-
mandated multi-site observational study to examine the risks of extended-
release/long-acting opioids]."},{"name":"Kristine Steffen, PharmD,
PhD","credentials":["Research Scientist\n","Neuropsychiatric Research
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: [Bariatric surgery
and pharmacokinetics (Lisdexamfetamine)]; NIH [Bariatric surgery and weight
outcomes]; Sanford Profile/NDSU [Diabetes and microbiome]; Center for Protease
Research/NDSU [Bariatric surgery and microbiome]."},{"name":"Murray B Stein, MD,
MPH","credentials":["Editor-in-Chief — Psychiatry\n","Section Editor — Anxiety
Disorders\n","Professor of Psychiatry and Family Medicine & Public
Health\n","University of California San
Diego"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Social
anxiety disorder]. Consultant/Advisory Boards: Actelion Pharmaceuticals [Anxiety
and Traumatic Stress-Related Disorders]; Dart Neuroscience [Anxiety and Traumatic
Stress-Related Disorders]; Janssen [Anxiety and Traumatic Stress-Related
Disorders]; Oxeia Biopharmaceuticals [Traumatic Brain Injury]; Neurocrine [Tardive
Dyskinesia]; Pfizer [Anxiety and Traumatic Stress-Related Disorders]. Equity
Ownership/Stock Options: Oxeia Biopharmaceuticals [Traumatic Brain Injury];
Resilience Therapeutics [PTSD]."},{"name":"Joanna Steinglass, MD","credentials":
["Assistant Professor of Clinical Psychiatry\n","Columbia University Medical
Center/New York State Psychiatric Institute"],"disclosure":""},{"name":"Donna
Stewart, CM, MD, FRCPC","credentials":["University Professor of Psychiatry, Ob-Gyn,
Medicine, Surgery, Anesthesia, and Family and Community Medicine\n","University of
Toronto and University Health Network"],"disclosure":"Consultant/Advisory Board:
Eli Lilly [Depression during pregnancy (Duloxetine)]."},{"name":"Maxine Stitzer,
PhD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","Johns
Hopkins University School of Medicine; Bayview Medical Center"],"disclosure":""},
{"name":"Jon Stone, FRCP, PhD","credentials":["Honorary Reader in
Neurology\n","University of Edinburgh"],"disclosure":""},{"name":"Jeffrey Stovall,
MD","credentials":["Associate Professor of Psychiatry\n","Vanderbilt School of
Medicine"],"disclosure":""},{"name":"Eric Strain, MD","credentials":["Director,
Johns Hopkins Center for Substance Abuse Treatment and Research\n","Medical
Director, Behavioral Pharmacology Research Unit\n","Johns Hopkins University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes [Opioid
Use Disorder (naltrexone, buprenorphine, methadone)]. Consultant/Advisory Boards:
Individior [Opioid use disorder (Buprenorphine)]; Egalet [Opioid use disorder];
Pinney Associates [Opioid use disorder]; The Oak Group [Opioid use disorder
(Treatment placement decision sets)]. Other Financial Interest: Alkermes [Opioid
use disorder]."},{"name":"Jeffrey Strawn, MD","credentials":["Associate Professor
of Psychiatry\n","University of Cincinnati"],"disclosure":"Grant/Research/Clinical
Trial Support: Edgemont [Adult generalized anxiety disorder (Extended-release
lorazepam)]; Eli Lilly [Pediatric generalized anxiety disorder (Duloxetine)];
Forest Research Laboratories [Pediatric major depressive disorder (Vilazodone)];
Lundbeck [Adult PTSD]; Neuronetics [Pediatric major depressive disorder
(Transcranial magnetic stimulation)]; National Institute of Mental Health
[Neurofunctional predictors of treatment response in adolescents with generalized
anxiety disorder treated with escitalopram]; Assurex Health [Generalized anxiety
disorder (provided genotyping for a federally-funded study of escitalopram in
children and adolescents with GAD)]. Royalties: Springer Publishing."},{"name":"T.
Scott Stroup, MD, MPH","credentials":["Professor of Psychiatry\n","Columbia
University"],"disclosure":"Research/Grant/Clinical Trial Support: Teva [Tardive
dyskinesia (Deutetrabenazine)]."},{"name":"Kathryn N Suh, MD, FRCPC","credentials":
["Associate Professor of Medicine\n","University of Ottawa,
Canada"],"disclosure":""},{"name":"Trisha Suppes, MD","credentials":["Professor of
Psychiatry & Behavioral Science\n","Stanford/VA Bipolar and Depression Research
Program"],"disclosure":"Grant/Research/Clinical Trial Support: National Institute
of Mental Health [Mood disorders (R34 moodswings)]; VA CSP [Mood disorders
(Aripiprazole, Bupropion)]; Pathways Genomics [Mood disorders (Genetic testing)];
Stanley Medical Research Institute [Mood disorders (Infliximab)]; NIH (Mood
Disorders); NIDA (Smoking Cessation); Palo Alto Health Sciences (PTSD).
Consultant/Advisory Boards: Lundbeck [Mood disorders]; Merck [Mood disorders];
Sunovion [Mood disorders]; VA OR&D PRIME Care [Depression (Genetic testing)]. Other
Financial Interest: Jones and Bartlett [royalties]; UpToDate [royalties].
Consultant/Advisory Boards: Sunovion [Mood disorders]."},{"name":"Holly A Swartz,
MD","credentials":["Professor of Psychiatry\n","University of Pittsburgh School of
Medicine"],"disclosure":""},{"name":"Mary M Sweeney, PhD","credentials":
["Instructor of Psychiatry and Behavioral Sciences\n","Johns Hopkins University
School of Medicine; Bayview Medical Center"],"disclosure":""},{"name":"Richard
Swinson, MD","credentials":["Professor Emeritus\n","McMaster
University"],"disclosure":""},{"name":"Robyn Sysko, PhD","credentials":["Assistant
Professor of Psychiatry\n","Icahn School of Medicine at Mt.
Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: Shire Pharmaceuticals
[Co-Investigator of Investigator Initiated Application funded to examine
definitions of binge eating among patients with binge eating disorder
(Lisdexamfetamine)]; Noom Inc. [Small business grant R42 DK116370-01 to use a
randomized-controlled study to test the efficacy of a combined smartphone app and
health coaching system (Noom Coach) to improve adherence, and
behavioral/psychosocial outcomes for patients receiving bariatric surgery.
\r\nRole: Co-Investigator; Bariatric surgery]. Consultant/Advisory Boards (spouse):
Noom, Inc [Smartphone applications (Noom Monitor, a CBT Weightloss monitoring app
developed as part of an NIMH small business grant R41MH096435 and currently being
tested in a Phase II NIMH grant R42MH096435)]. Patent Holder (spouse): Noom, Inc
[Smartphone applications (Noom Monitor, a CBT Weightloss monitoring app developed
as part of an NIMH small business grant R41MH096435]."},{"name":"Puneeta Tandon,
MD, FRCPC","credentials":["Associate Professor of Medicine\n","University of
Alberta, Canada"],"disclosure":""},{"name":"Charles T Taylor, PhD","credentials":
["Assistant Professor of Psychiatry\n","University of California San
Diego"],"disclosure":""},{"name":"Scott A Teitelbaum, MD","credentials":["Professor
of Psychiatry\n","University of Florida"],"disclosure":""},{"name":"Scott Temple,
PhD","credentials":["Clinical Professor, Department of Psychiatry\n","University of
Iowa Hospitals & Clinics"],"disclosure":""},{"name":"Jeanette M Tetrault, MD, FACP,
FASAM","credentials":["Associate Professor of Medicine\n","Yale University School
of Medicine"],"disclosure":""},{"name":"Michael Thase, MD","credentials":
["Professor of Psychiatry\n","University of Pennsylvania School of
Medicine"],"disclosure":"Grant/Research Support: Agency for Healthcare Research and
Quality [Depression]; Alkermes [Depression]; Forest Pharmaceuticals [Depression
(Vilazodone, Milnacipran)]; National Institute of Mental Health [Depression];
Otsuka Pharmaceuticals [Depression (Aripiprazole)]; PharmaNeuroboost [Depression];
Roche [Depression]; Johnson & Johnson [Depression
(Risperidone, Esketamine)]; Avenir [Depression]. Consultant/Advisory Boards:
Alkermes [Depression]; Allergan [Depression(Botulinium Toxin A)]; AstraZeneca
[Depression (Quetiapine)]; Bristol-Myers Squibb [Depression (Aripiprazole)];
Cerecor [Depression (Olanzapine, Olanzapine Fluoxetine Combination, Duloxetine)];
Eli Lilly [Depression]; Forest Laboratories [Depression (Vilazodone
Levomilnacipran)]; Gerson Lehrman Group [Depression]; GlaxoSmithKline [Depression];
Guidepoint Global [Depression]; H Lundbeck [Depression (Vortioxetine)]; MedAvante
[Depression]; Merck [Depression (Mirtazapine)]; Moksha8 [Depression]; Neuronetics
[Depression (Neurostar TMS Device)]; Novartis [Depression]; Johnson & Johnson
[Depression (Risperidone, Esketamine]; Otsuka [Depression (Aripiprazole)]; Pamlab
[Depression (L Methylfolate)]; Pfizer [Depression (Venlafaxine, Desvenlafaxine,
Ziprasidone)]; PGx [Depression (Mixed Amphetamine Salts)]; Shire [Depression];
Sunovion Pharmaceuticals [Depression (Lurasidone)]; Takeda [Depression
(Vortioxetine)]; Genentech [Depression]. Employment (Spouse): Peloton Advantage.
Equity Ownership/ Stock Options: MedAvante."},{"name":"Kenneth Thompson,
MD","credentials":["Clinical Associate Professor of Medicine\n","Pennsylvania State
University"],"disclosure":""},{"name":"Geoffrey H Tofler, MD","credentials":
["Professor of Cardiology\n","University of Sydney, Australia\n","Research
Fellow\n","Harvard Medical School"],"disclosure":""},{"name":"Glenn J Treisman, MD,
PhD","credentials":["Professor of Psychiatry and Behavioral Sciences, Professor of
Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":""},
{"name":"Jürgen Unützer, MD, MPH","credentials":["Professor of
Psychiatry\n","University of Washington"],"disclosure":""},{"name":"Michael Van
Ameringen, MD","credentials":["Professor of Psychiatry and Behavioural
Neurosciences\n","McMaster University"],"disclosure":"Grant/Research/Clinical Trial
Support: Janssen-Ortho Inc [Depression (Sirukumab); Social Anxiety Disorder (JNJ-
42165279)]; Pfizer Inc [Social Anxiety Disorder (sertraline)]; Servier [Generalized
Anxiety Disorder (Agomelatine)]. Consultant/Advisory Boards: Janssen-Ortho Inc
[ADHD (Methylphenidate)]; Lundbeck [ADHD (Methylphenidate)]; Purdue [Depression
(Vortioxetine)]."},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":
["Associate Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol
Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Eduard Vieta,
MD, PhD","credentials":["Professor of Psychiatry\n","University of
Barcelona"],"disclosure":"Grant/Research/Clinical Trial Support: AB-Biotics
[Bipolar Disorder (Pharmacogenetic Kit)]; Ferrer [Bipolar Disorder (Loxapine)];
Forest Research Institute [Bipolar Disorder (Cariprazine)]; Gedeon Richter [Bipolar
Disorder (Cariprazine)]; Janssen [Bipolar Disprder (Esketamine)]; Lundbeck [Bipolar
Disorder (Vortioxetine)]; Telefonica [Psychiatry (software)]. Consultant/Advisory
Boards: AB-Biotics [Bipolar Disorder (Pharmacogenetic Kit)]; Allergan [Bipolar
Disorder (Rapastinel)]; Dainippon Sumitomo Pharma [Bipolar Disorder (Lurasidone)];
Ferrer [Bipolar Disorder (Loxapine)]; Forest Research Institute [Bipolar Disorder
(Cariprazine)]; Gedeon Richter [Bipolar Disorder (Cariprazine)]; Janssen [Bipolar
Disprder (Esketamine)]; Lundbeck [Bipolar Disorder (Vortioxetine)]; Otsuka
[Bipolar Disorder (Aripiprazole depot)]; Sunovion [Bipolar Disorder (Lurasidone)];
Takeda [Bipolar Disorder (Vortioxetine)]; Telefonica [Psychiatry (software)]."},
{"name":"Simone Vigod, MD, MSc, FRCPC","credentials":["Associate Professor of
Psychiatry\n","University of Toronto"],"disclosure":""},{"name":"Adele Viguera,
MD","credentials":["Director of Research, Women’s Mental Health; Assistant
Professor in Psychiatry\n","Cleveland Clinic Lerner College of
Medicine"],"disclosure":""},{"name":"Jeffrey Vittengl, PhD","credentials":
["Professor of Psychology\n","Truman State University"],"disclosure":""},
{"name":"John T Walkup, MD","credentials":["Director, Division of Child and
Adolescent Psychiatry \n","Vice Chair, Department of Psychiatry \n","Weill Cornell
Medical College New York Presbyterian Hospital"],"disclosure":""},{"name":"B
Timothy Walsh, MD","credentials":["Professor of Psychiatry\n","Columbia
University"],"disclosure":""},{"name":"Elizabeth Weil, MD","credentials":
["Associate Professor of Psychiatry\n","University of New Mexico School of
Medicine"],"disclosure":""},{"name":"James C West, MD","credentials":["Associate
Professor of Psychiatry\n","Uniformed Services University of the Health
Sciences"],"disclosure":""},{"name":"Mark Zimmerman, MD","credentials":["Associate
Professor of Psychiatry\n","Brown University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Depression]. Other
Financial Interest: Otsuka Pharmaceuticals [Licensing fee]."},{"name":"Sidney
Zisook, MD","credentials":["Distinguished Professor of Psychiatry\n","UC San
Diego"],"disclosure":""},{"name":"Christie Zunker, PhD, CPH, CHES","credentials":
["Evaluation Scientist at ICF International"],"disclosure":""}]},{"name":"Peer
Reviewers","contributors":[{"name":"Elias Aboujaoude, MD","credentials":["Clinical
Professor\n","Stanford University School of Medicine"],"disclosure":""},
{"name":"Steve Adelman, MD","credentials":["Clinical Associate Professor of
Psychiatry\n","University of Massachusetts School of Medicine"],"disclosure":""},
{"name":"Daniel Alford, MD, MPH","credentials":["Associate Professor of
Medicine\n","Boston University School of Medicine"],"disclosure":""},
{"name":"Evelyn Attia, MD","credentials":["Professor of Psychiatry\n","Columbia
University Medical Center"],"disclosure":"Grant/Research Support: Eli Lilly [Eating
disorders (Olanzapine)]."},{"name":"David Avery, MD","credentials":["Professor of
Psychiatry and Behavioral Sciences\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"Catherine Ayers, PhD","credentials":
["Assistant Professor\n","UC San Diego School of Medicine"],"disclosure":""},
{"name":"Richard Balon, MD","credentials":["Professor (Clinical) of Psychiatry and
Anesthesiology\n","Wayne State University School of Medicine"],"disclosure":""},
{"name":"Steven L Batki, MD","credentials":["Professor of Psychiatry, University of
California, San Francisco\n","Chief, Substance Abuse Programs and Director,
Addiction Research Program, San Francisco VA Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alkermes Inc [Alcohol
pharmacotherapy (Extended-release naltrexone injection)]. Consultant/Advisory
Boards: Alkermes Inc [Alcohol pharmacotherapy (Extended-release naltrexone
injection)]."},{"name":"Boris Birmaher, MD","credentials":["Endowed Chair in Early
Onset Bipolar Disease, Professor of Psychiatry\n","University of Pittsburgh, School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: National
Institutes of Mental Health [Bipolar disorder]. Other Financial Interests:
Royalties for books [Bipolar and major depressive disorders]."},{"name":"Michael H
Bloch, MD, MS","credentials":["Assistant Professor\n","Yale Child Study
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Neurocrine
Biosciences [Tourette syndrome (valbenazine)]; Janssen Pharmaceuticals [Depression
(esketamine)]. Consultant/Advisory Boards: Therapix Biosciences [Tourette
syndrome]."},{"name":"Hillary R Bogner, MD, MSCE","credentials":["Assistant
Professor\n","University of Pennsylvania"],"disclosure":""},{"name":"Bethany Brand,
PhD","credentials":["Professor of Psychology \n","Towson
University"],"disclosure":""},{"name":"Robert W Buchanan, MD","credentials":
["Professor of Psychiatry\n","University of Maryland School of
Medicine"],"disclosure":""},{"name":"Leah Casuto, MD","credentials":["Adjunct
Assistant Professor of Psychiatry-COM, Department of Psychiatry & Behavioral
Neuroscience\n","University of Cincinnati College of Medicine"],"disclosure":""},
{"name":"Les Citrome, MD","credentials":["Clinical Professor of Psychiatry and
Behavioral Sciences\n","New York Medical College"],"disclosure":"Speaker’s Bureau:
Acadia [Parkinson's Disease psychosis (pimavanserin)]; Alkermes [schizophrenia
(aripiprazole lauroxil); Allergan [schizophrenia, bipolar mania (asenapine,
cariprazine)]; Janssen [schizophrenia, schizoaffective disorder (paliperidone
palmitate)]; Lundbeck [schizophrenia, major depressive disorder(brexpiprazole,
aripiprazole monohydrate)]; Merck [insomnia (suvorexant)]; Neurocrine [tardive
dyskinesia (valbenazine)]; Otsuka [schizophrenia, major depressive disorder,
bipolar disorder (brexpiprazole, aripiprazole monohydrate, aripiprazole)]; Pfizer
[schizophrenia, bipolar disorder (ziprasidone)]; Shire [binge eating disorder
(lisdexamfetamine)]; Sunovion [schizophrenia, bipolar disorder (lurasidone)];
Takeda [major depressive disorder (vortioxetine)]; Teva [tardive dyskinesia
(deutetrabenazine)]; Vanda [schizophrenia (iloperidone)]. Consultant/Advisory
Boards: Acadia [Parkinson's Disease psychosis (pimavanserin)]; Alkermes
[schizophrenia (aripiprazole lauroxil)]; Allergan [schizophrenia, bipolar mania
(asenapine, cariprazine)]; Boehringer Ingelheim [schizophrenia (investigational
drug)]; Forum [schizophrenia (investigational drug)]; Genentech [schizophrenia
(investigational drug)]; Intra-Cellular Therapeutics [schizophrenia
(investigational drug)]; Janssen [schizophrenia, schizoaffective disorder
(paliperidone palmitate)]; Lundbeck [schizophrenia, major depressive
disorder(brexpiprazole, aripiprazole monohydrate)]; Merck [insomnia (suvorexant)];
Neurocrine [tardive dyskinesia (valbenazine)]; Noven [schizophrenia
(investigational drug)]; Otsuka [schizophrenia, major depressive disorder, bipolar
disorder (brexpiprazole, aripiprazole monohydrate, aripiprazole)]; Pfizer
[schizophrenia,
bipolar disorder (ziprasidone)]; Reckitt Benckiser [schizophrenia (investigational
drug)]; Reviva [schizophrenia (investigational drug)]; Shire [binge eating
disorder (lisdexamfetamine)]; Sunovion [schizophrenia, bipolar disorder
(lurasidone)]; Teva [tardive dyskinesia (deutetrabenazine)]; Vanda [schizophrenia
(iloperidone)]. Equity Ownership/Stock Options: Bristol-Myers Squibb; Eli Lilly;
Johnson & Johnson; Merck; Pfizer."},{"name":"Heidi Combs, MD, MS","credentials":
["Associate Professor of Psychiatry and Behavioral Sciences\n","University of
Washington School of Medicine"],"disclosure":""},{"name":"Daniel F Connor,
MD","credentials":["Lockean Distinguished Professor of Psychiatry\n","Chief
Division of Child & Adolescent
Psychiatry\n","Univ"],"disclosure":"Consultant/Advisory Boards: Shire [ADHD
(stimulants)]; Supernus [Aggression (molindone)]."},{"name":"Deborah Cowley,
MD","credentials":["Professor of Psychiatry and Behavioral Sciences\n","University
of Washington"],"disclosure":""},{"name":"Scott J Crow, MD","credentials":
["Professor of Psychiatry\n","University of Minnesota"],"disclosure":""},
{"name":"Michael Devlin, MD","credentials":["Professor of Clinical
Psychiatry\n","Columbia University College of Physicians and
Surgeons"],"disclosure":""},{"name":"Peter Freed, MD","credentials":["Assistant
Professor of Clinical Psychiatry\n","Columbia University"],"disclosure":""},
{"name":"Oliver Freudenreich, MD","credentials":["Associate Professor of
Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Avanir [Schizophrenia (AVP-786)]; Janssen [Schizophrenia (long-acting
injectable)]; Otsuka [Schizophrenia (brexpiprazole)]. Consultant/Advisory Boards:
Janssen [Schizophrenia drug development]. Other Financial Interest: Global Medical
Education [CME talk on schizophrenia]."},{"name":"Manuel Fuentes,
MD","credentials":["Assistant Professor\n","Psychiatry Department\n","Faculty of
Medicine Clínica Alemana/Universidad del Desarrollo"],"disclosure":""},
{"name":"David R Gastfriend, MD","credentials":["Scientific Advisor\n","Treatment
Research Institute"],"disclosure":"Grant/Research/Clinical Support: Treatment
Research Institute [Medication assisted treatment (American Society of Addiction
Medicine criteria)]; PCORI [Medication assisted treatment (American Society of
Addiction Medicine criteria)]; DynamiCareHealth. Consultant/Advisory Boards:
Alkermes [Addiction (naltrexone)]; BioCorRx [Addiction (naltrexone)]; Indivior
[Addiction (buprenorphine)]; Kaleo [Addiction (naloxone auto-injector)]; Purdue
Pharma [Addiction]. Employment: DynamiCare Health [Addiction (Contingency
management)]. Equity Ownership/Stock Options: Alkermes (naltrexone); DynamiCare
Health [Addiction (Contingency management applications)]. Other Financial Interest:
American Society of Addiction Medicine (Continuum Royalties)."},{"name":"Bradley N
Gaynes, MD, MPH","credentials":["Professor of Psychiatry, Associate Chair for
Psychiatry Research Training and Education \n","University of North Carolina School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: M-3 [Research to
assess feasibility of administering a general psychiatric screening and monitoring
tool in psychiatric clinics]."},{"name":"Michael Gitlin, MD","credentials":
["Professor of Clinical Psychiatry\n","Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Benjamin Goldstein, MD, PhD, FRCP","credentials":
["Associate Professor of Psychiatry, Pharmacology, and Psychological Clinical
Science\n","University of Toronto"],"disclosure":""},{"name":"Paul Grekin,
MD","credentials":["Clinical Professor of Psychiatry\n","University of Washington
Medical School"],"disclosure":""},{"name":"Ceri Hadda, MD","credentials":
["Assistant Clinical Professor of Psychiatry\n","NYU School of
Medicine"],"disclosure":""},{"name":"Victoria Hendrick, MD","credentials":
["Clinical Professor\n","Department of Psychiatry and Biobehavioral Sciences David
Geffen School of Medicine, UCLA"],"disclosure":""},{"name":"Philip G Janicak,
MD","credentials":["Adjunct Professor, Department of Psychiatry and Behavioral
Sciences\n","Northwestern University, Feinberg School of
Medicine"],"disclosure":"Speaker's Bureau: Neuronetics [Depression (transcranial
magnetic stimulation)]; TMS Solutions [Depression (transcranial magnetic
stimulation)]. Consultant/ Advisory Boards: Neuronetics [Depression (transcranial
magnetic stimulation)]; Otsuka [Psychosis (participate in their nonpromotional
PsyhU program on various topics, including mood and psychotic disorders)]."},
{"name":"Danielle Johnson, MD, FAPA","credentials":["Adjunct Assistant Professor of
Psychiatry\n","University of Cincinnati College of Medicine/Lindner Center of
HOPE"],"disclosure":""},{"name":"Courtney Kassar, MD","credentials":["Assistant
Professor of Psychiatry\n","University of Cincinnati, Lindner Center of
Hope"],"disclosure":""},{"name":"Ryan Kimmel, MD","credentials":["Associate
Professor of Psychiatry and Behavioral Sciences\n","University of Washington School
of Medicine"],"disclosure":""},{"name":"Nicole Lanouette, MD","credentials":
["Associate Clinical Professor\n","Department of Psychiatry\n","Medical Director,
Neuropsychiatry and Behavioral Medicine Services, UCSD"],"disclosure":""},
{"name":"Roberto Lewis-Fernandez, MD","credentials":["Professor of Psychiatry,
Columbia University Medical Center\n","Director of the NY State Center of
Excellence for Cultural Competence and the Hispanic Treatment Program, NYS
Psychiatric Institute"],"disclosure":"Equity Ownership/Stock Options:
GlaxoSmithKline."},{"name":"Richard J Loewenstein, MD","credentials":["Medical
Director, The Trauma Disorders Program\n","Sheppard Pratt Health
System"],"disclosure":""},{"name":"Shari I Lusskin, MD, FAPA","credentials":
["Clinical Professor of Psychiatry, Obstetrics, Gynecology, and Reproductive
Sciences \n","Icahn School of Medicine at Mount Sinai\n","Attending\n","Mount Sinai
Medical Center"],"disclosure":"Employment: Reproductive Toxicology Foundation,
Director of Psychopharmacologic Agents. Other Financial Interest: Pfizer
[Consultant regarding sertraline and venlafaxine litigation (Sertraline,
venlafazine)]); Forest Laboratories [Consultant regarding escitalopram litigation
(Escitalopram)]."},{"name":"Sloan Manning, MD","credentials":["Adjunct Associate
Professor\n","University of North Carolina, School of
Medicine"],"disclosure":"Speaker's Bureau: Lundbeck [Mood disorders in primary care
(Vortioxetine)]; Otsuka [Mood disorders in primary care (Brexpiprazole)]; Sunovion
[Mood disorders in primary care (Lurasidone)]; Takeda [Mood disorders in primary
care (Vortioxetine)]. Consultant/Advisory Boards: Lundbeck [Mood disorders in
primary care (Vortioxetine)]; Otsuka [Mood disorders in primary care
(Brexpiprazole)]; Sunovion [Mood disorders in primary care (Lurasidone)]; Takeda
[Mood disorders in primary care (Vortioxetine)] Sunovion ADHD in primary care
(dasotraline)"},{"name":"Theo Manschreck, MD","credentials":["Professor of
Psychiatry\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Otsuka [early psychosis (aripiprazole)]. Consultant/Advisory Boards:
Otsuka-Lundbeck [new antidepressant]."},{"name":"Joseph O Merrill, MD,
MPH","credentials":["Associate Professor of Medicine \n","University
of Washington School of Medicine"],"disclosure":""},{"name":"Erik Messamore, MD,
PhD","credentials":["Assistant Professor of Psychiatry\n","University of
Cincinnati"],"disclosure":""},{"name":"Karen Miotto, MD","credentials":["Professor
of Psychiatry\n","UCLA School of Medicine"],"disclosure":""},{"name":"James E
Mitchell, MD","credentials":["Professor - Department of Psychiatry and Behavioral
Science\n","University of North Dakota School of Medicine and Health
Sciences\n","\n","Research Scientist\n","Neuropsychiatric Research
Institute"],"disclosure":""},{"name":"Pauline S Powers, MD","credentials":
["Professor of Psychiatry Emerita\n","University of South Florida College of
Medicine"],"disclosure":"Employment: Fairwinds Treatment Center."},
{"name":"Jitender Sareen, MD, FRCPC","credentials":["Professor and Department of
Psychiatry, Max Rady College of Medicine, University of
Manitoba"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson."},
{"name":"Jason J Schafer, PharmD, BCPS, AAHIVP","credentials":["Assistant
Professor, Department of Pharmacy Practice\n","The Jefferson School of Pharmacy,
Thomas Jefferson University"],"disclosure":""},{"name":"Tracey G Skale,
MD","credentials":["Chief Medical Officer, Greater Cincinnati Behavioral Health
Services\n","Volunteer Faculty, University of Cincinnati College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Otsuka [Schizophrenia (Long-
acting injection aripiprazole)]. Speaker’s Bureau: Sunovion [Schizophrenia/bipolar
disorder (lurasidone)]; Otsuka/Lundbeck [Schizophrenia (Aripiprazole,
brexpiprazole)]."},{"name":"Scott H Stewart, MD, MS","credentials":["Associate
Professor of Medicine\n","University at Buffalo, State University of New
York"],"disclosure":""},{"name":"T. Scott Stroup, MD, MPH","credentials":
["Professor of Psychiatry\n","Columbia
University"],"disclosure":"Research/Grant/Clinical Trial Support: Teva [Tardive
dyskinesia (Deutetrabenazine)]."},{"name":"Thomas N Wise, MD","credentials":
["Professor of Psychiatry\n","Johns Hopkins University School of Medicine
\n","George Washington School of Medicine (Associate Chair)"],"disclosure":""},
{"name":"Mark Zimmerman, MD","credentials":["Associate Professor of
Psychiatry\n","Brown University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Alkermes [Depression]. Other
Financial Interest: Otsuka Pharmaceuticals [Licensing fee]."}]}]}